APRILBIO CO.,LTD. revenue for the last year amounted to 28.00 B KRW, the most of which — 27.51 B KRW — came from its highest performing source at the moment, Bio Innovation and New Drug Development, the year earlier bringing 200.00 M KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought APRILBIO CO.,LTD. 27.51 B KRW, and the year before that — 200.00 M KRW.